The First Approved Treatment in Japan: OTEZLA for Behcet’s Syndrome
What is Bechet’s Syndrome? Recurrent oral and vaginal ulcers, skin lesions, and inflammation of the eyes are the main symptoms of Behcet's Disease , a rare and persistent disorder. Behcet's Syndrome currently has no known cure, thus treatment focuses on symptom management. According to a recent study by DelveInsight Business Research, off-label medicines have taken the lead in the market for treating Behcet's Disease . The paper emphasizes the increasing frequency of Behcet's Disease worldwide and the dearth of effective treatments. Off-label remedies are frequently used to address symptoms because there aren't any approved treatments for them. OTEZLA, REMICADE, and HUMIRA are the three off-label treatments for Behcet's Disease that are most frequently utilised. Key developments in the Behcet’s syndrome treatment space so far In 2014, t he FDA authorised OTEZLA , a phosphodiesterase 4 (PDE4) inhibitor, for the treatment of psoriasis and psoriatic arthritis. Whe...